8101 - 8110 of 8808 Results
Title
Year
-
OPENTitle: Inactive S. aureus Cas9 downregulates alpha-synuclein and reduces mtDNA damage and oxidative stress levels in human stem cell model of Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-023-45078-3Best OA location URL: https://www.nature.com/articles/s41598-023-45078-3.pdfCitation Count: 8
-
OPENTitle: Free-water imaging of the hippocampus is a sensitive marker of Alzheimer's diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 24Issue #:Start Page: 101985End Page: 101985Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2019.101985Best OA location URL: https://doi.org/10.1016/j.nicl.2019.101985Citation Count: 52
-
OPENTitle: Subcortical Volumes Differ in Parkinson’s Disease Motor Subtypes: New Insights into the Pathophysiology of Disparate SymptomsJournal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2016.00356Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnhum.2016.00356/pdfCitation Count: 56
- Cysteine oxidation and redox signaling in dopaminergic neurons physiology and in Parkinson’s disease2019OPENTitle: Cysteine oxidation and redox signaling in dopaminergic neurons physiology and in Parkinson’s diseaseJournal Name: Current Opinion in PhysiologyPublisher: Elsevier BVVol: 9Issue #:Start Page: 73End Page: 78Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.cophys.2019.04.025Best OA location URL: https://ars.els-cdn.com/content/image/1-s2.0-S2468867319300859-fx1_lrg.jpgCitation Count: 9
- Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles2024OPENTitle: Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profilesJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.92775.3Best OA location URL: https://doi.org/10.7554/elife.92775.3Citation Count: 5
-
OPENTitle: Influence of species and processing parameters on recovery and content of brain tissue‐derived extracellular vesiclesJournal Name: Journal of Extracellular VesiclesPublisher: WileyVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/20013078.2020.1785746Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1080/20013078.2020.1785746Citation Count: 104
-
OPENTitle: Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 18Issue #: 11Start Page: 998End Page: 1008Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30285-6Best OA location URL: http://www.thelancet.com/article/S1474442219302856/pdfCitation Count: 460
-
OPENTitle: Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortexJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 2Start Page: 571End Page: 582Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.09.023Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4315751Citation Count: 82
-
RESTRICTEDTitle: DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.Journal Name: NeuropharmacologyPublisher: Elsevier BVVol: 131Issue #:Start Page: 116End Page: 127Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2017.11.046Citation Count: 20
-
OPENTitle: Minimal Clinically Important Difference for UPDRS‐III in Daily PracticeJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 4Start Page: 448End Page: 450Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12632Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12632Citation Count: 46